The novel treatment of the medication represents a significant development in the management of diabetes mellitus type 2. Unlike existing medications, tirzepatide targets two pathways – the GLP-1 hormone and https://tirzepatide-peptide622405.luwebs.com/42973298/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment